| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Mbx Biosciences, Inc. (MBX) has 5 insiders with recent SEC Form 4 filings, including 14 buys and 2 sells. MBX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 5.22M | $231.17M | - | |
| CEO | 727.7K | $32.23M | - | |
| Dir | 74.2K | $3.29M | - | |
| Other | 14.8K | $654.1K | - | |
| Dir | 12.5K | $553.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | Azoulay Salomon | Chief Medical Officer | Sell | 231 | $29.54 | $6,823.74 | -1.5% | - | - | |
| May 6, 2026 | Hawryluk P. Kent83 | President &CEO | Sell | 607 | $29.54 | $17,930.78 | - | - | - | |
| Mar 13, 2026 | Hawryluk P. Kent83 | President &CEO | Buy | 18,500 | $28.41 | $525,662.70 | +4.0% | +33.0% | - | |
| Oct 20, 2025 | Hawryluk P. Kent83 | President &CEO | Buy | 20,000 | $13.64 | $272,790.00 | +4.5% | +203.2% | - | |
| Oct 17, 2025 | Hoerter Steven L. | Director | Buy | 20,000 | $13.25 | $264,984.00 | New | +209.5% | - | |
| Sep 26, 2025 | Heron Patrick J87 | Director, 10% Owner | Buy | 666,666 | $18.00 | $11,999,988.00 | +14.6% | +76.5% | - | |
| Apr 8, 2025 | Pescovitz Ora H. | Director | Buy | 7,693 | $5.89 | $45,311.77 | +46.2% | +122.5% | +446.8% | |
| Feb 18, 2025 | Gordon Carl L74 | Director, 10% Owner | Buy | 190,672 | $10.60 | $2,020,755.60 | +1.9% | +11.5% | +269.8% | |
| Feb 18, 2025 | Orbimed Advisors LLC67 | Director, 10% Owner | Buy | 190,672 | $10.60 | $2,020,755.60 | +1.9% | +11.5% | +269.8% | |
| Feb 4, 2025 | Hawryluk P. Kent83 | President &CEO | Buy | 50,000 | $10.69 | $534,500.00 | +12.6% | +10.4% | +251.1% |